Materialsammlung zur internen Radiodekontamination von Personen

140. U. S. Armed Forces Radiobiology Research Institute, “Medical Management
of Radiological Casualties”, Handbook, 2nd Ed., Military Medical Operations,
Bethesda, Maryland 20889-5603, April 2003
141. U. S. Army Center for Health Promotion and Preventive Medicine, „Radiological
Sources of Potential Exposure and/or Contamination“, Technical
Guide TG-238, (1999)
142. U. S. Department of Health and Human Services, Food and Drug Administration,
Center for Drug Evaluation and Research (CDER),“Guidance for Industry:
Internal Radioactive Contamination — Development of Decorporation
Agents”, March 2006
143. Verordnung über den Schutz vor Schäden durch ionisierende Strahlen
(Strahlenschutzverordnung – StrlSchV) vom 20. Juli 2001 (BGBl. I Nr. 38 S.
1714) zuletzt geändert durch Art. 2 § 3 Abs. 31 des Gesetzes vom 01. September
2005 (BGBl. I Nr. 55 S. 2618)
144. Verger P., Aurengo A., Geoffroy B., and Le Guen B., „Iodine Kinetics and
Effectiveness of Stable Iodine, Prophylaxis After Intake of Radioactive Iodine:
A Review“, Thyroid 11 (4), pp. 353 – 360 (2001)
145. Verzijl J. M., Wierckx F. C. J., Van Dijk A., Savelkoul J. F. T., Glerum J. H.,
„Hemodialysis as a Potential Method for the Decontamination of Persons
Exposed to Radiocesium“, Health Physics 69(4), pp. 543-548 (1995)
146. Vilensky J. A., Redman K., “British Anti-Lewisite (Dimercaprol): An amazing
history”, Ann. Emerg. Med. 41, pp.378-383 (2003)
147. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W., „Early Chelation
Therapy for Injected Pu-238 and Am-241 in the Rat: Comparison of 3,4,3-
LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA“, International Journal
of Radiation Biology, 63(6), pp. 785 – 793 (1993)
148. Volf V., Rencová J., Jones M.M. and Singh P.K., „Combined Chelation
Treatment for Polonium after Simulated Wound Contamination in Rat“, Int.
J. Radiat. Biol., 68(4), pp. 395 – 404 (1995)
149. Waller E.A., Stodilka R.Z., Leach K. and Prud'homme-Lalonde L., “Literature
Survey on Decorporation of Radionuclides from the Human Body”, Defence
R&D Canada – Ottawa, Technical Memorandum, DRDC Ottawa TM
2002-042, April 2002
150. Wang R. S., Chen J. X., Liu Z.W.,“The adsorption behaviour of microamounts
of radium on inorganic ion exchangers“, Journal of Radioanalytical
and Nuclear Chemistry, 111(2), pp. 289-295 (1987)
151. Williams D. R., „Wounds: Decontamination and Healing“, Coord. Chem.
Rev. 151, pp. 161 – 174 (1996)
152. Wolff J., „Perchlorate and the Thyroid Gland“, Pharmacol. Rev. 50(1), pp.
89 – 105 (1998)
153. Wood R., Sharp C., Gourmelon P., Le Guen B., Stradling G.N., Taylor D.M.
and Hengé-Napoli M.-H.. “Decorporation Treatment – Medical Overview”,
Rad. Prot. Dosim. 87 (1), pp. 51-57 (2000)
154. World Health Organisation: „Guidelines for Iodine Prophylaxis following
Nuclear Accidents“. Update 1999
155. Young B. F., Bivins H. G.,“Evaluation of Gastric Emptying Using Radionuclides:
Gastric Lavage Versus Ipecac-Induced Emesis“, Ann. Emerg. Med. 22,
pp. 1423 – 1427 (1993)
156. Xu K., Ge W., Liang G., Wang L., Yang Z., Wang Q., Hsing I. and Xu B.,
„Bisphosphonate-containing supramolecular hydrogels for topical decorpora-
123